Evidence map›Paper›PMID 37325503›Full record

ReviewExploration (Beijing, China)2022

Therapeutic gas-releasing nanomedicines with controlled release: Advances and perspectives.

Yaw Opoku-Damoah, Run Zhang, Hang T Ta, Zhi Ping Xu

Abstract readReview
In one paragraph

Review in Exploration (Beijing, China), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Review
  2. Therapeutic Gases in Biomedicine: Updates on Nitric Oxide and Beyond.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yaw Opoku-DamoahAustralian Institute for Bioengineering and Nanotechnology The University of Queensland Brisbane Queensland Australia.
Run ZhangAustralian Institute for Bioengineering and Nanotechnology The University of Queensland Brisbane Queensland Australia.ORCID https://orcid.org/0000-0002-0943-824X
Hang T TaAustralian Institute for Bioengineering and Nanotechnology The University of Queensland Brisbane Queensland Australia.ORCID https://orcid.org/0000-0003-1188-0472
Zhi Ping XuAustralian Institute for Bioengineering and Nanotechnology The University of Queensland Brisbane Queensland Australia.ORCID https://orcid.org/0000-0001-6070-5035

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanoparticle-based drug delivery has become one of the most popular approaches for maximising drug therapeutic potentials. With the notable improvements, a greater challenge hinges on the formulation of gasotransmitters with unique challenges that are not met in liquid and solid active ingredients. Gas molecules upon release from formulations for therapeutic purposes have not really been discussed extensively. Herein, we take a critical look at four key gasotransmitters, that is, carbon monoxide (CO), nitric oxide (NO), hydrogen sulphide (H

Indexed as

gas‐releasing moleculesgas‐releasing nanomedicinesnanoparticle delivery systemsstimulus‐triggered gas releasetherapeutic gases

Identifiers

PMID37325503
PMCPMC10190986

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.